{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T19:22:10Z","timestamp":1711567330753},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.2169\/internalmedicine.0993-22","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T22:10:05Z","timestamp":1671574205000},"page":"717-722","source":"Crossref","is-referenced-by-count":1,"title":["Time Course of Coagulopathy Evaluated with Rotational Thromboelastometry in Patients with Severe Coronavirus Disease 2019"],"prefix":"10.2169","volume":"62","author":[{"given":"Takeshi","family":"Yagi","sequence":"first","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Harada","sequence":"additional","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Shin","sequence":"additional","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Esaki","sequence":"additional","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ayata","sequence":"additional","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Koga","sequence":"additional","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Kaneda","sequence":"additional","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Tsuruta","sequence":"additional","affiliation":[{"name":"Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ribes A, Vardon-Bounes F, Memier V, et al. Thromboembolic events and COVID-19. Adv Biol Regul 77: 100742, 2020.","DOI":"10.1016\/j.jbior.2020.100735"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nahum J, Morichau-Beauchant T, Daviaud F, et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19). JAMA Netw 3: e2010478, 2020.","DOI":"10.1001\/jamanetworkopen.2020.10478"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191: 145-147, 2020.","DOI":"10.1016\/j.thromres.2020.04.013"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Iba T, Levy JH, Levi M, Thacil J. Coagulopathy in COVID-19. J Thromb Haemost 18: 2103-2109, 2020.","DOI":"10.1111\/jth.14975"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA. Personalizing antithrombotic therapy in COVID-19: role of thromboelastography and thromboelastometry. Thromb Haemost 120: 1594-1596, 2020.","DOI":"10.1055\/s-0040-1714217"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nougier C, Benoit R, Simon M, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-CoV2 associated thrombosis. J Thromb Haemost 18: 2215-2219, 2020.","DOI":"10.1111\/jth.15016"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Coccheri S. COVID-19: the crucial role of blood coagulation and fibrinolysis. Intern Emerg Med 15: 1369-1373, 2020.","DOI":"10.1007\/s11739-020-02443-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kruse JM, Magomedov A, Kurreck A, et al. Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis. Crit Care 24: 676, 2020.","DOI":"10.1186\/s13054-020-03401-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wright FL, Vogler TO, Moore EE, et al. Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection. Am Coll Surg 231: 193-203, 2020.","DOI":"10.1016\/j.jamcollsurg.2020.05.007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46: 1089-1098, 2020.","DOI":"10.1007\/s00134-020-06062-x"},{"key":"11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/SHK.0000000000001666","volume":"55","author":"C Creel-Bulos","year":"2021","unstructured":"11. Creel-Bulos C, Auls SA, Caridi-Scheible M. Fibrinolysis shutdown and thrombosis in a COVID-19 ICU. Shock 55: 845-846, 2021.","journal-title":"Shock","ISSN":"http:\/\/id.crossref.org\/issn\/1073-2322","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hincker A, Feit J, Sladen RN, Wagener G. Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery. Crit Care 18: 549, 2014.","DOI":"10.1186\/s13054-014-0549-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Almskog LM, Wikman A, Svensson J, et al. Rotational thromboelastometry results are associated with care level in COVID-19. Thromb J Thrombolysis 51: 437-445, 2021.","DOI":"10.1007\/s11239-020-02312-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis 50: 281-286, 2020.","DOI":"10.1007\/s11239-020-02130-7"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Tsantes AE, Tsantes AG, Kokoris SI, et al. COVID-19 infection-related coagulopathy and viscoelastic methods: a paradigm for their clinical utility in critical illness. Diagnostics 10: 817, 2020.","DOI":"10.3390\/diagnostics10100817"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ibanez C, Perdomo J, Calvo A, et al. High D dimers and low global fibrinolysis coexist in COVID-19 patients: what is going on in there. J Thromb Thrombolysis 51: 308-312, 2021.","DOI":"10.1007\/s11239-020-02226-0"},{"key":"17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/SHK.0000000000001660","volume":"55","author":"MA Mazzeffi","year":"2021","unstructured":"17. Mazzeffi MA, Chow JH, Tanaka K. COVID-19 associated hypercoagulability: manifestations, mechanism, and management. Shock 55: 465-471, 2021.","journal-title":"Shock","ISSN":"http:\/\/id.crossref.org\/issn\/1073-2322","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Collett LW, Gluck S, Strickland RM, Reddi BJ. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): an observational point prevalence cohort study. Aust Crit Care 34: 155-159, 2021.","DOI":"10.1016\/j.aucc.2020.07.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Meizoso JP, Moore HB, Moore EE. Fibrinolysis shutdown in COVID-19: clinical manifestations, molecular mechanisms, and therapeutic implications. Am Coll Surg 232: 995-1003, 2021.","DOI":"10.1016\/j.jamcollsurg.2021.02.019"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/5\/62_0993-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T03:28:14Z","timestamp":1677900494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/5\/62_0993-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0993-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"article-number":"0993-22"}}